Trials / Completed
CompletedNCT05809674
Polarization Sensitive Optical Coherence Tomography
Polarization Sensitive Optical Coherence Tomography - Phase II: A Pilot Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 178 (actual)
- Sponsor
- Singapore Eye Research Institute · Academic / Other
- Sex
- All
- Age
- 10 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to use the polarization sensitive optical coherence tomography (PS-OCT) developed by Singapore Eye Research Institute, to evaluate the potential OCT scleral biomarkers capable of predicting risk of myopia progression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Polarization sensitive optical coherence tomography (PS-OCT) | The PS-OCT is a prototype, also known as an early version of a medical device, specially developed by the Ocular Imaging Research Group, Singapore Eye Research Institute, for prediction of myopia progression. It has not been approved for use in any other country. There is currently no method to identify who is at risk of myopia progression. The PS-OCT device will provide the capabilities of OCT scleral biomarkers, which may have the potential to identify individuals at high risk for myopia. |
Timeline
- Start date
- 2022-03-10
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2023-04-12
- Last updated
- 2023-04-12
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT05809674. Inclusion in this directory is not an endorsement.